Form 4: Encompass Health EVP Douglas Coltharp Reports Stock Transactions

Sentiment:

SEC Filing


Douglas Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports acquisition of shares through restricted stock awards.

Summary

  • Douglas Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, filed a Form 4 detailing changes in beneficial ownership.
  • On February 28, 2024, Coltharp acquired 27,820 shares of Encompass Health Common Stock as a result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 25, 2022.
  • Coltharp also acquired 5,248 shares of Encompass Health Common Stock as an annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan on February 28, 2024.
  • Following these transactions, Coltharp directly owns 136,227 shares and indirectly owns 125,631 shares through an irrevocable trust for the benefit of children.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as the stock acquisitions reflect confidence by a key executive in the company's performance.

Positives

  • The acquisition of shares indicates confidence in the company's performance and future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The stock acquisitions could have a slightly positive impact on shareholder confidence.

Key Dates

DateDescription
02/25/2022Date of performance share unit award
02/28/2024Date of stock acquisitions
02/29/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.